Amalgamated Bank Tg Therapeutics, Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q2 2024

A detailed history of Amalgamated Bank transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 4,868 shares of TGTX stock, worth $116,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,868

Previous 4,558 6.8%

Holding current value

$116,004

Previous $69,000 26.09%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.32 - $19.19 $4,129 - $5,948	310 Added 6.8%	4,868 $87,000
Q1 2024 Apr 23, 2024	SELL	$13.02 - $21.3 $198,437 - $324,633	-15,241 Reduced 76.98%	4,558 $69,000
Q4 2023 Feb 06, 2024	SELL	$6.68 - $18.81 $6,118 - $17,229	-916 Reduced 4.42%	19,799 $338,000
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $28,374 - $64,155	1,833 Added 9.71%	20,715 $514,000
Q1 2023 May 02, 2023	SELL	$10.23 - $19.34 $23,692 - $44,791	-2,316 Reduced 10.93%	18,882 $284,000
Q3 2022 Nov 09, 2022	BUY	$4.57 - $8.4 $1,553 - $2,856	340 Added 1.63%	21,198 $125,000
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $979 - $2,792	-262 Reduced 1.24%	20,858 $89,000
Q1 2022 Jun 30, 2022	SELL	$7.81 - $20.45 $12,511 - $32,760	-1,602 Reduced 7.05%	21,120 $201,000
Q4 2021 Feb 15, 2022	SELL	$15.2 - $35.51 $1,231 - $2,876	-81 Reduced 0.36%	22,722 $432,000
Q3 2021 Oct 29, 2021	SELL	$21.78 - $40.45 $30,557 - $56,751	-1,403 Reduced 5.8%	22,803 $759,000
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $259,415 - $390,798	7,982 Added 49.2%	24,206 $939,000
Q1 2021 May 13, 2021	SELL	$41.61 - $54.3 $25,465 - $33,231	-612 Reduced 3.64%	16,224 $782,000
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $17,512 - $38,045	693 Added 4.29%	16,836 $875,000
Q3 2020 Oct 30, 2020	BUY	$18.49 - $27.24 $31,839 - $46,907	1,722 Added 11.94%	16,143 $432,000
Q2 2020 Aug 10, 2020	SELL	$8.9 - $21.84 $1,290 - $3,166	-145 Reduced 1.0%	14,421 $281,000
Q1 2020 May 13, 2020	SELL	$7.14 - $15.99 $5,205 - $11,656	-729 Reduced 4.77%	14,566 $143,000
Q4 2019 Feb 13, 2020	BUY	$5.1 - $11.2 $8,328 - $18,289	1,633 Added 11.95%	15,295 $170,000
Q3 2019 Nov 13, 2019	SELL	$5.38 - $8.99 $575 - $961	-107 Reduced 0.78%	13,662 $77,000
Q2 2019 Aug 14, 2019	BUY	$6.27 - $8.65 $86,331 - $119,101	13,769 New	13,769 $119,000

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Tg Therapeutics, Inc. Transaction History